J. Sayas Catalan (Madrid, Spain), M. Lebret (GRENOBLE, France)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Early intervention with non-invasive respiratory therapies in mild acute respiratory distress syndrome secondary to COVID-19
S. Suárez Escudero (Madrid, Spain), D. López-Padilla (Madrid, Spain), J. Terán Tinedo (Madrid, Spain), V. Parra León (Madrid, Spain), S. López Martín (Madrid, Spain), F. Caballero Segura (Madrid, Spain), C. Castro Riera (Madrid, Spain), A. Cerezo Lajas (Madrid, Spain), E. Ojeda Castillejo (Madrid, Spain), B. Recio Moreno (Madrid, Spain), L. Puente Maestú (Madrid, Spain)
|   |
High O2 flow rate is necessary to reach acceptable FiO2 levels in CPAP-treated patients with severe COVID-19
M. Lebret (Rouen, France), E. Fresnel (Rouen, France), G. Prieur (Le Havre, France), J. Quieffin (Le Havre, France), J. Dupuis (Isneauville, France), B. Lamia (Le Havre, France), Y. Combret (Le Havre, France), C. Médrinal (Le Havre, France)
| |
A Retrospective Review of Advanced Respiratory Support for COVID-19 Associated ARDS in a Ward-Based Setting
F. Easton (Bristol, United Kingdom), K. Millington (Bristol, United Kingdom), C. Baggott (Bristol, United Kingdom), S. Winearls (Bristol, United Kingdom), N. Brown (Bristol, United Kingdom), J. Morgan (Bristol, United Kingdom), K. Curtis (Bristol, United Kingdom)
| |
Characteristics and outcomes of COVID-19 patients in an Italian sub-intensive care unit
S. Abram (Cuneo, Italy), F. Tosello (Cuneo, Italy), J. Giamello (Turin, Italy), G. Paglietta (Turin, Italy), E. Bernardi (Cuneo, Italy), A. Allione (Cuneo, Italy), G. Cavalot (Cuneo, Italy), S. Bernardi (Cuneo, Italy), L. Dutto (Cuneo, Italy), F. Corsini (Cuneo, Italy), B. Lorenzati (Cuneo, Italy), G. Martini (Cuneo, Italy), A. Sciolla (Cuneo, Italy), G. Lauria (Cuneo, Italy)
| |
Outcomes of patients with COVID-19 pneumonia treated with CPAP
R. Di Tria (Torino, Italy), G. Ferrari (Torino, Italy), P. Righini (Torino, Italy), A. Marchisio (Torino, Italy), C. Caponnetto (Torino, Italy), V. Gallo (Torino, Italy), S. Bassini (Torino, Italy), R. Prota (Torino, Italy)
| |
Noninvasive ventilatory support in patients with COVID-19 pneumonia in high dependency unit: a single center study
S. Radosavljevic (Sremska Kamenica, Republic of Serbia), I. Andrijevic (Sremska Kamenica, Republic of Serbia), J. Matijasevic (Sremska Kamenica, Republic of Serbia), D. Obradovic (Sremska Kamenica, Republic of Serbia), B. Joves (Sremska Kamenica, Republic of Serbia), S. Krunic (Sremska Kamenica, Republic of Serbia), S. Sovilj-Gmizic (Sremska Kamenica, Republic of Serbia), S. Pekovic (Sremska Kamenica, Republic of Serbia), S. Milutinov-Ilic (Sremska Kamenica, Republic of Serbia), M. Vukoja (Sremska Kamenica, Republic of Serbia)
| |
CPAP compared to Conventional Oxygen Therapy as ceiling of care in COVID-19 patients with Advanced Frailty: A retrospective cohort study
Y. Noeman Ahmed (Southend, United Kingdom), M. Noeman (University College London, United Kingdom), A. Bedir (Southend, United Kingdom), I. El Sayed (Alexandria, Egypt), A. Roshdy (Alexandria, Egypt), G. Koduri (Southend University Hospital, United Kingdom), S. Gokaraju (Southend University Hospital, United Kingdom), P. Ayuen (St Peters Hospital, United Kingdom), N. Abuelela (St Peters Hospital, United Kingdom), S. Sharma (St Peters Hospital, United Kingdom), D. Amran (Southend University Hospital, United Kingdom), D. Powrie (Southend University Hospital, United Kingdom)
| |
Timely start of HFNC treatment is beneficial for the outcome in COVID-19
L. Tokhi (Värnamo, Sweden), M. Roglic (Värnamo, Sweden), J. Paluero (Värnamo, Sweden), M. Labor (Värnamo, Sweden)
| |
High-velocity nasal insufflation therapy in Patients with COVID-19 pneumonia
A. Metwaly (Assiut, Egypt), D. Magdy (Assuit, Egypt)
| |
Comparison of CPAP outcomes in COVID-19 between first and second wave
A. Babu (Basildon, United Kingdom), M. Shafiq (Basildon, United Kingdom), N. Hassan (Basildon, United Kingdom), U. Dawar (Basildon, United Kingdom), M. Pittman (Basildon, United Kingdom)
| |
Outcomes in patients requiring CPAP for COVID-19 infection in non-ITU settings
B. Pippard (Stockton on Tees, United Kingdom), H. Bright (Stockton on Tees, United Kingdom), V. Chew (Stockton on Tees, United Kingdom), G. Miller (Stockton on Tees, United Kingdom), K. Conroy (Stockton on Tees, United Kingdom), B. Prudon (Stockton on Tees, United Kingdom), V. Jeebun (Stockton on Tees, United Kingdom)
| |
Risk factors for mortality in HFNO-treated Covid-19 positive patients – a pilot study
M. Labor (Värnamo, Sweden), L. Tokhi (Värnamo, Sweden), J. Paluero (Värnamo, Sweden), M. Roglic (Värnamo, Sweden)
| |
Predictors of mortality in COVID-19 patients requiring CPAP
M. Shafiq (Basildon Essex, United Kingdom), A. Babu (Basildon Essex, United Kingdom), N. Hassan (Basildon Essex, United Kingdom), U. Dawar (Basildon Essex, United Kingdom), M. Pittman (Basildon Essex, United Kingdom)
| |
Predictors of continuous positive airway pressure (CPAP) response in severe hypoxaemic respiratory failure due to COVID-19 pneumonitis
J. Shaw (Greater Manchester, United Kingdom), E. Springate (Greater Manchester, United Kingdom), J. Thompson (Merseyside, United Kingdom), W. Falconer (Greater Manchester, United Kingdom), H. Law (Greater Manchester, United Kingdom), G. Ng Man Kwong (Greater Manchester, United Kingdom)
| |
Rox index as predictor of HFNC success in acute respiratory failure due to SARS-CoV-2 pneumonia
S. Ferrer Espinosa (Valencia, Spain), I. Bocigas Huéscar (Valencia, Spain), J. Sancho Chinesta (Valencia, Spain), E. Burés Sales (Valencia, Spain), J. Signes-Costa Miñana (Valencia, Spain)
| |
Outcomes and characteristics of COVID-19 patients treated with CPAP/ HFNO outside of the Intensive Care setting
D. Sykes (Hull, United Kingdom), K. Thuthu (Hull, United Kingdom), O. Brown (Hull, United Kingdom), A. Parthasarathy (Hull, United Kingdom), M. Crooks (Hull, United Kingdom), S. Faruqi (Hull, United Kingdom)
| |
Correlation between lactate dehydrogenase and therapeutic strategy in Covid-19 pneumonia
R. Cianci (Napoli, Italy), L. Capitelli (Napoli, Italy), M. Buonincontro (Napoli, Italy), R. Donizzetti (Napoli, Italy), D. Cuomo (Napoli, Italy), A. Prisco (Napoli, Italy), F. Squillante (Napoli, Italy), V. Bocchino (Napoli, Italy)
| |
Cost-effectiveness of the use of Continuous Positive Airway Pressure in COVID-19 patients at Medway NHS Foundation Trust
T. Gower (London, United Kingdom), R. Sarkar (London, United Kingdom), S. Banerjee (London, United Kingdom), C. Froneman (London, United Kingdom), A. Ryan (London, United Kingdom)
| |
How far is too far? A review of non-invasive ventilation as ceiling of care in COVID-19 patients not suitable for invasive mechanical ventilation.
E. Springate (Oldham, United Kingdom), J. Shaw (Oldham, United Kingdom)
| |
AWAKE PRONE POSITION IN CRITICAL AND SEVERE COVID-19 PATIENTS UNDERGOING NONINVASIVE RESPIRATORY SUPPORT: A RETROSPECTIVE MULTICENTER COHORT STUDY.
I. Castaniere (Modena, Italy), R. Tonelli (Modena, Italy), L. Tabbì (Modena, Italy), L. Pisani (Bologna, Italy), I. Prediletto (Bologna, Italy), V. Comellini (Bologna, Italy), R. Fantini (Modena, Italy), A. Marchioni (Modena, Italy), D. Andrisani (University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, Modena, Italy, Italy), F. Gozzi (Modena, Italy), G. Bruzzi (Modena, Italy), L. Manicardi (Modena, Italy), I. Bassi (Bologna, Italy), M. Carpano (Bologna, Italy), F. Tagariello (Bologna, Italy), G. Corsi (Bologna, Italy), S. Nava (Bologna, Italy), E. Clini (Modena, Italy)
| |